Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT00124280 · COMPLETED

Trial details

NCT number: NCT00124280
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Carcinoma

Start date: 2005-07-01
Primary completion: 2007-10-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.